• One-step TUNEL FITC Apoptosis Detection Kit Workflow

  2026-08-14

  Build a reproducible DNA fragmentation assay for tissue sections, adherent cells, suspension cells, and flow cytometry. This workflow connects TUNEL-positive cell mapping with the omics-anchored reproductive toxicity findings reported for gestational polystyrene nano-plastics exposure.

• Trelagliptin succinate in Bone and Diabetes Research

  2026-08-13

  Trelagliptin succinate, also known as SYR-472 succinate, supports integrated studies of DPP-4 biology, glucose regulation, and osteoblast differentiation. This practical guide connects assay setup, AMPK–RUNX2 validation, metabolic models, and troubleshooting for more reproducible diabetes mellitus research.

• 3X (DYKDDDDK) Peptide: Uses & Workflow

  2026-08-13

  The 3X (DYKDDDDK) Peptide is a compact, hydrophilic FLAG epitope reagent for antibody-based detection and affinity workflows. Its reported solubility and storage conditions support routine handling, while metal sensitivity and sequence verification remain important controls.

• Methyl-β-cyclodextrin: Membrane Workflow Guide

  2026-08-12

  Methyl-β-cyclodextrin is a research reagent for controlled membrane cholesterol extraction and related studies of lipid organization, membrane fluidity, and cholesterol-dependent signaling. It should be optimized for each cell and assay system, used promptly after solution preparation, and not used for diagnostic, therapeutic, or medical applications.

• Fenipentol: From Choleresis to Translational Biology

  2026-08-12

  Fenipentol, also known as 1-Phenyl-1-pentanol, offers a distinctive bridge between historical secretion physiology, ESR1-linked molecular hypotheses, and modern translational study design. This thought-leadership article explains how to validate its biology without conflating it with the related but chemically distinct 1-Phenyl-2-Pentanol, identified in recent hepatic stellate cell research.

• PPT: An ERα Perturbation Framework for LUAD

  2026-08-11

  PPT (Propyl Pyrazole Triol) is more than a selective ERα agonist: it can serve as a causal perturbation tool for separating receptor biology from biomarker correlation. This guide connects PPT assay design with FOXM1–ERα findings in female lung adenocarcinoma while defining practical controls, limits, and translational opportunities.

• TBST for Cleaner Immunoassay Signal

  2026-08-11

  TBST combines isotonic buffering with mild non-ionic detergent action to reduce nonspecific binding in Western blotting, immunofluorescence, immunohistochemistry, and immunocytochemistry. Its greatest practical value is workflow consistency: one defined buffer can support blocking, antibody dilution, and post-incubation washing while preserving interpretable target-specific signal.

• Annexin V-FITC/PI Apoptosis Assay Kit Workflow

  2026-08-10

  Use Annexin V-FITC and PI staining to separate viable, early apoptotic, and membrane-compromised cells in a rapid, two-parameter workflow. This guide translates findings from a conjugated linoleic acid study into practical assay design, gating, optimization, and troubleshooting for intestinal epithelial injury models.

• CHIR 99021 Trihydrochloride for Organoid Assays

  2026-08-09

  CHIR 99021 trihydrochloride is a selective GSK-3 inhibitor for studying stem-cell state, intestinal organoid composition, insulin signaling, and glucose metabolism. This article presents an assay-design framework that separates pathway engagement from proliferation and differentiation outcomes.

• LY364947: TGF-β Type I Receptor Kinase Inhibitor

  2026-08-08

  LY364947 gives researchers a reversible way to interrogate TGF-β-driven Smad2 signaling, EMT, fibrosis, and retinal injury responses. This practical guide covers solvent handling, pathway-resolved assay design, combination studies inspired by pancreatic cancer research, and troubleshooting strategies.

• 2-Deoxy-D-glucose in Immunometabolism Assays

  2026-08-07

  Discover how 2-Deoxy-D-glucose can function as a calibrated metabolic perturbation in whole-blood immune assays, not merely as a glycolysis inhibitor. This guide connects assay design, cytokine interpretation, cancer metabolism, and viral research while distinguishing established evidence from practical recommendations.

• Targeted mRNA Delivery to Islet β Cells via Lipid Nanopartic

  2026-08-07

  A recent study demonstrates the use of conjugated lipid nanoparticles for efficient and selective mRNA delivery to pancreatic islet β cells in both mouse and human models. By enabling functional expression of PD-L1 mRNA, this platform delays autoimmune diabetes progression, highlighting a promising avenue for β cell-directed therapies and immune modulation.

• Stiripentol: LDH Inhibitor for Astrocyte-Neuron Lactate Modu

  2026-08-06

  Stiripentol is a noncompetitive LDH inhibitor that modulates lactate-to-pyruvate conversion, essential for astrocyte-neuron metabolic coupling and Dravet syndrome research. Its validated mechanism and robust solubility make it a key tool for epilepsy research and metabolic pathway dissection.

• ATG4B Nuclear Translocation Links Energy Deficiency to DNA R

  2026-08-06

  This study elucidates a novel mechanism by which cellular energy deficiency impairs DNA repair in acute myeloid leukemia (AML) via ATG4B nuclear translocation, which inhibits PRMT1-mediated methylation of MRE11. These findings highlight a key pathway connecting metabolic stress to genomic instability and offer new directions for targeted intervention in leukemia progression.

• Energy Deficiency, ATG4B, and DNA Repair in AML Progression

  2026-08-05

  This article reviews new evidence connecting cellular energy deficiency to impaired DNA repair in acute myeloid leukemia (AML) via ATG4B nuclear translocation. The findings illuminate a specific mechanism by which metabolic stress exacerbates genomic instability, suggesting new therapeutic strategies for AML.

13069 records 1/872 page Next 12345 下5页 Last page